Browse by Journal Title

2022

Fibrin-targeting molecular MRI in inflammatory CNS disorders.
Lohmeier, J., Silva, R.V., Tietze, A., Taupitz, M., Kaneko, T., Prüss, H., Paul, F., Infante-Duarte, C., Hamm, B., Caravan, P. and Makowski, M.R.
European Journal of Nuclear Medicine and Molecular Imaging 49 (11): 3692–3704. September 2022

2011

Automatic, three-segment, MR-based attenuation correction for whole-body PET/MR data.
Schulz, V., Torres-Espallardo, I., Renisch, S., Hu, Z.B., Ojha, N., Boernert, P., Perkuhn, M., Niendorf, T., Schaefer, W.M., Brockmann, H., Krohn, T., Buhl, A., Guenther, R.W., Mottaghy, F.M. and Krombach, G.A.
European Journal of Nuclear Medicine and Molecular Imaging 38 (1): 138-152. January 2011

2005

Radioimmunotherapy using 131I-rituximab in patients with advanced stage B-cell non-Hodgkin's lymphoma: initial experience.
Bienert, M., Reisinger, I., Srock, S., Humplik, B.I., Reim, C., Kroessin, T., Avril, N., Pezzutto, A. and Munz, D.L.
European Journal of Nuclear Medicine and Molecular Imaging 32 : 1225-1233. 1 January 2005

2004

Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology.
Amthauer, H., Denecke, T., Rau, B., Hildebrandt, B., Huenerbein, M., Ruf, J., Schneider, U., Gutberlet, M., Schlag, P.M., Felix, R. and Wust, P.
European Journal of Nuclear Medicine and Molecular Imaging 31 (6): 811-819. 1 January 2004